unknown
Stage
2
Investors
About
Girihlet develops ImmuneScanner, a diagnostic tool to monitor autoimmune treatments and help patients and doctors select the best options. They collaborate with Mayo Clinic to study treatment effects on Ankylosing Spondylitis and create platforms for discovering strategies for complex immune diseases.
Explore Girihlet's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.